Taiko PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Taiko PharmaceuticalLtd has a total shareholder equity of ¥6.7B and total debt of ¥3.2B, which brings its debt-to-equity ratio to 47.6%. Its total assets and total liabilities are ¥13.2B and ¥6.5B respectively.
Key information
47.6%
Debt to equity ratio
JP¥3.21b
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥5.48b |
| Equity | JP¥6.74b |
| Total liabilities | JP¥6.48b |
| Total assets | JP¥13.22b |
Financial Position Analysis
Short Term Liabilities: 4574's short term assets (¥9.1B) exceed its short term liabilities (¥3.0B).
Long Term Liabilities: 4574's short term assets (¥9.1B) exceed its long term liabilities (¥3.4B).
Debt to Equity History and Analysis
Debt Level: 4574 has more cash than its total debt.
Reducing Debt: 4574's debt to equity ratio has increased from 0% to 47.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4574 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4574 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 29% each year